1. Home
  2. HOLX vs DGX Comparison

HOLX vs DGX Comparison

Compare HOLX & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$75.01

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$179.06

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOLX
DGX
Founded
1985
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Electronics
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
20.5B
IPO Year
1990
1996

Fundamental Metrics

Financial Performance
Metric
HOLX
DGX
Price
$75.01
$179.06
Analyst Decision
Hold
Buy
Analyst Count
15
15
Target Price
$79.64
$194.07
AVG Volume (30 Days)
2.9M
1.1M
Earning Date
02-04-2026
01-29-2026
Dividend Yield
N/A
1.75%
EPS Growth
N/A
14.49
EPS
2.49
8.51
Revenue
$4,100,500,000.00
$10,850,000,000.00
Revenue This Year
$6.69
$12.37
Revenue Next Year
$5.74
$3.52
P/E Ratio
$30.12
$21.44
Revenue Growth
1.74
13.74
52 Week Low
$51.90
$148.70
52 Week High
$76.29
$197.55

Technical Indicators

Market Signals
Indicator
HOLX
DGX
Relative Strength Index (RSI) 65.02 40.42
Support Level $74.77 $178.61
Resistance Level $75.34 $185.12
Average True Range (ATR) 0.27 2.89
MACD -0.11 -0.61
Stochastic Oscillator 57.59 0.95

Price Performance

Historical Comparison
HOLX
DGX

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: